Parental smoking and other risk factors for wheezing bronchitis in children

E Rylander1, G Pershagen, M Eriksson

  • 1Department of Epidemiology, Karolinska Institute, Stockholm, Sweden.

Insights

Parental smoking significantly increases the risk of childhood wheezing bronchitis and asthma. Reducing environmental exposures like smoke and ensuring longer breastfeeding can dramatically lower incidence.

Area of Science:

  • Pediatric respiratory health
  • Environmental epidemiology
  • Public health

Background:

  • Wheezing bronchitis and asthma are common respiratory illnesses in young children.
  • Identifying preventable risk factors is crucial for primary prevention strategies.

Purpose of the Study:

  • To investigate etiologic factors for wheezing bronchitis and asthma in children up to four years of age.
  • To assess the impact of parental smoking and other environmental factors on childhood respiratory illnesses.

Main Methods:

  • Population-based case-control study.
  • 199 hospitalized children (cases) and 351 controls were interviewed.
  • Data collected via home interviews regarding parental smoking, heredity, infections, and feeding practices.

Main Results:

  • Parental smoking showed a relative risk of 1.8 (27% population attributable proportion), strongest with maternal smoking in infants under 18 months.
  • Atopic heredity, recurrent upper respiratory infections, and short breastfeeding (<3 months) interacted with parental smoking.
  • Combined environmental factors (smoking, short breastfeeding, pets) accounted for 43% of cases, with greater impact in younger children.

Conclusions:

  • Parental smoking is a major modifiable risk factor for childhood wheezing and asthma.
  • Environmental factors significantly influence respiratory health in early childhood.
  • Primary prevention focusing on reducing parental smoking and optimizing breastfeeding can substantially decrease the incidence of these conditions.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...